Home | All trials

[RDF data]
Trial NCT00000319

Resource URI: http://static.linkedct.org/resource/trials/NCT00000319
PropertyValue
linkedct:brief_title Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/9346>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 55 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000319
rdfs:label Trial NCT00000319
linkedct:lastchanged_date August 16, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/150283>
linkedct:nct_id NCT00000319
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Buprenorphine Maintenance Dose Schedule and Treatment Setting
linkedct:org_study_id NIDA-09803-2
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/50041>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000319>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/14365>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/14373>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/1648>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/20604>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/26212>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/6422>
linkedct:secondary_id R01-09803-2
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date June 1996
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.
rdf:type linkedct:trials
linkedct:verification_date June 1996